Rapid diagnostic tests
WHO has developed tools to strengthen capacities on the use of microscopy and systems to promote quality assurance of malaria microscopy.
Prompt malaria diagnosis either by microscopy or rapid diagnostic tests (RDTs) is recommended by WHO for all patients with suspected malaria before they are given treatment. Early and accurate diagnosis is essential both for effective management of the disease and for strong malaria surveillance.
Parasite-based diagnostic testing significantly reduces illness and death by enabling health providers to swiftly distinguish between malarial and non-malarial fevers and select the most appropriate treatment. It improves the overall management of patients with febrile illnesses and may also help reduce the emergence and spread of drug resistance.
Where quality-assured diagnosis is readily available, health-care providers should only give antimalarial treatment to patients who test positive, while those who test negative should be assessed for other causes of fever.
Since 2010, when WHO recommended testing of all suspected malaria cases, the proportion of patients receiving a malaria diagnostic test has increased significantly.
The WHO Guidelines for malaria bring together all current WHO recommendations on malaria in one easy-to-navigate web-based platform. They are a living resource that will be updated periodically as new evidence becomes available. The Guidelines are available in Arabic, English, French and Spanish.
WHO has developed tools to strengthen capacities on the use of microscopy and systems to promote quality assurance of malaria microscopy.
WHO provides tools and related material to ensure quality assured microscopy-based diagnosis for patients suspected of malaria.
Nucleic acid amplification tests (NAATs) enable sensitive detection of low density malaria infections.